Form 4: Bluebird Bio's Chief Medical Officer Sells Shares to Cover Tax Obligations

Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., sold 584 shares of common stock on March 3, 2025, to cover tax withholding obligations.

Summary

• Richard A. Colvin, the Chief Medical Officer of bluebird bio, Inc., executed a sale of 584 shares of common stock on March 3, 2025.
• The sale was conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units.
• The shares were sold at an average weighted price of $3.9194, with individual prices ranging from $3.85 to $4.09.
• Following the transaction, Colvin directly owns 7,610 shares of bluebird bio, Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, reflecting insider transactions. It's common for executives to sell shares to cover tax obligations related to vesting equity awards.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates